News

Haplogen, a biotechnology company developing antiviral therapies, and CeMM, the Center for Molecular Medicine of the Austrian Academy of Sciences, today announced that they are making available their large collection of human cell lines that are deficient for single genes, which they have been building over the past three years as part of a public-private partnership.
| 3 min read

Scientists now have made the first-ever accurate determination of a solid-state triple point in a substance called vanadium dioxide, which is known for switching rapidly – in as little as one 10-trillionth of a second – from an electrical insulator to a conductor, and thus could be useful in various technologies.
| 3 min read







